🎉 M&A multiples are live!
Check it out!

Lumibird Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lumibird and similar public comparables like CurveBeam AI, Clarity Pharmaceuticals, and Australian Clinical Labs.

Lumibird Overview

About Lumibird

Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.


Founded

1970

HQ

France
Employees

1.1K+

Website

quantel.fr

Financials

LTM Revenue $259M

LTM EBITDA $49.3M

EV

$566M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lumibird Financials

As of September 2025, Lumibird reported last 12-month revenue of $259M and EBITDA of $49.3M.

In the same period, Lumibird achieved $16.7M in LTM net income.

See Lumibird valuation multiples based on analyst estimates

Lumibird P&L

In the most recent fiscal year, Lumibird reported revenue of $243M and EBITDA of $35.9M.

Lumibird expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lumibird valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $259M XXX $243M XXX XXX XXX
Gross Profit n/a XXX $151M XXX XXX XXX
Gross Margin n/a XXX 62% XXX XXX XXX
EBITDA $49.3M XXX $35.9M XXX XXX XXX
EBITDA Margin 19% XXX 15% XXX XXX XXX
EBIT $28.2M XXX $17.2M XXX XXX XXX
EBIT Margin 11% XXX 7% XXX XXX XXX
Net Profit $16.7M XXX $6.6M XXX XXX XXX
Net Margin 6% XXX 3% XXX XXX XXX
Net Debt XXX XXX $89.7M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Lumibird Stock Performance

Lumibird has current market cap of EUR 449M (or $520M), and EV of EUR 489M (or $566M).

Market Cap Evolution

Lumibird Stock Data

As of October 17, 2025, Lumibird's stock price is EUR 20 (or $24).

See Lumibird trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$566M $520M XXX XXX XXX XXX $0.74

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Lumibird Valuation Multiples

Lumibird's trades at 2.3x EV/Revenue multiple, and 15.7x EV/EBITDA.

See valuation multiples for Lumibird and 15K+ public comps

Lumibird Financial Valuation Multiples

As of October 17, 2025, Lumibird has market cap of $520M and EV of $566M.

Equity research analysts estimate Lumibird's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Lumibird has a P/E ratio of 31.2x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $520M XXX $520M XXX XXX XXX
EV (current) $566M XXX $566M XXX XXX XXX
EV/Revenue 2.2x XXX 2.3x XXX XXX XXX
EV/EBITDA 11.5x XXX 15.7x XXX XXX XXX
EV/EBIT 20.1x XXX 32.8x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E 31.2x XXX 78.9x XXX XXX XXX
EV/FCF 33.0x XXX 42.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lumibird Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Lumibird Margins & Growth Rates

Lumibird's last 12 month revenue growth is 9%

Lumibird's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Lumibird's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lumibird's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lumibird and other 15K+ public comps

Lumibird Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 9% XXX 9% XXX XXX XXX
EBITDA Margin 19% XXX 15% XXX XXX XXX
EBITDA Growth 21% XXX 28% XXX XXX XXX
Rule of 40 23% XXX 24% XXX XXX XXX
Bessemer Rule of X XXX XXX 43% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 55% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Lumibird Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lumibird M&A and Investment Activity

Lumibird acquired  XXX companies to date.

Last acquisition by Lumibird was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lumibird acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lumibird

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Lumibird

When was Lumibird founded? Lumibird was founded in 1970.
Where is Lumibird headquartered? Lumibird is headquartered in France.
How many employees does Lumibird have? As of today, Lumibird has 1.1K+ employees.
Is Lumibird publicy listed? Yes, Lumibird is a public company listed on PAR.
What is the stock symbol of Lumibird? Lumibird trades under LBIRD ticker.
When did Lumibird go public? Lumibird went public in 1997.
Who are competitors of Lumibird? Similar companies to Lumibird include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Lumibird? Lumibird's current market cap is $520M
What is the current revenue of Lumibird? Lumibird's last 12 months revenue is $259M.
What is the current revenue growth of Lumibird? Lumibird revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Lumibird? Current revenue multiple of Lumibird is 2.2x.
Is Lumibird profitable? Yes, Lumibird is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Lumibird? Lumibird's last 12 months EBITDA is $49.3M.
What is Lumibird's EBITDA margin? Lumibird's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Lumibird? Current EBITDA multiple of Lumibird is 11.5x.
What is the current FCF of Lumibird? Lumibird's last 12 months FCF is $17.1M.
What is Lumibird's FCF margin? Lumibird's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Lumibird? Current FCF multiple of Lumibird is 33.0x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.